Eugene Wyatt to Humans
This is a "connection" page, showing publications Eugene Wyatt has written about Humans.
Connection Strength
0.093
-
Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers. JCI Insight. 2018 05 03; 3(9).
Score: 0.018
-
Mutation-Based Therapy for Duchenne Muscular Dystrophy: Antisense Treatment Arrives in the Clinic. Circulation. 2017 09 12; 136(11):979-981.
Score: 0.018
-
Direct reprogramming of urine-derived cells with inducible MyoD for modeling human muscle disease. Skelet Muscle. 2016; 6:32.
Score: 0.016
-
Welcome to the splice age: antisense oligonucleotide-mediated exon skipping gains wider applicability. J Clin Invest. 2016 Apr 01; 126(4):1236-8.
Score: 0.016
-
Regulation and cytoprotective role of hexokinase III. PLoS One. 2010 Nov 03; 5(11):e13823.
Score: 0.011
-
Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies. Front Immunol. 2020; 11:1185.
Score: 0.005
-
Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes. JCI Insight. 2019 03 21; 4(6).
Score: 0.005
-
Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping. J Clin Invest. 2015 Nov 02; 125(11):4186-95.
Score: 0.004